Elevance Health Inc.
General ticker "ELV" information:
- Sector: Health Care
- Industry: Medical - Healthcare Plans
- Capitalization: $74.7B (TTM average)
Elevance Health Inc. follows the US Stock Market performance with the rate: 34.7%.
Estimated limits based on current volatility of 1.7%: low 389.09$, high 402.39$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-06-10, amount 1.72$ (Y1.76%)
- Total employees count: 97100 (-6.8%) as of 2025
- Top business risk factors: Healthcare cost prediction, Regulatory and compliance, Cybersecurity threats, Litigation risks, Market competition
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [267.70$, 420.34$]
- 2026-12-31 to 2027-12-31 estimated range: [291.60$, 449.40$]
Financial Metrics affecting the ELV estimates:
- Negative: with PPE of 11.5 at the end of fiscal year the price was high
- Positive: -5.39 < Operating profit margin, % of 4.07
- Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 4.45
- Positive: 19.24 < Shareholder equity ratio, % of 36.12 <= 42.59
- Positive: Inventory ratio change, % of 0.10 <= 0.78
- Positive: -0.02 < Operating cash flow per share per price, % of 5.59
- Positive: Industry inventory ratio change (median), % of 0.22 <= 0.28
- Positive: -4.41 < Investing cash flow per share per price, % of -1.75
- Positive: -9.55 < Industry operating profit margin (median), % of 0.37
- Positive: Interest expense per share per price, % of 1.83 <= 3.31
Short-term ELV quotes
Relationship graph
Long-term ELV plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $171,340.00MM | $176,810.00MM | $199,125.00MM |
| Operating Expenses | $162,595.00MM | $167,922.00MM | $191,013.00MM |
| Operating Income | $8,745.00MM | $8,888.00MM | $8,112.00MM |
| Non-Operating Income | $-1,030.00MM | $-984.00MM | $-1,402.00MM |
| Interest Expense | $1,030.00MM | $1,185.00MM | $1,402.00MM |
| Income(Loss) | $7,715.00MM | $7,904.00MM | $6,710.00MM |
| Taxes | $1,724.00MM | $1,933.00MM | $1,049.00MM |
| Net Income(Loss)* | $5,987.00MM | $5,980.00MM | $5,662.00MM |
| Stockholders Equity | $39,306.00MM | $41,315.00MM | $43,882.00MM |
| Assets | $108,928.00MM | $116,889.00MM | $121,494.00MM |
| Operating Cash Flow | $8,061.00MM | $5,808.00MM | $4,290.00MM |
| Capital expenditure | $1,296.00MM | $1,256.00MM | $1,116.00MM |
| Investing Cash Flow | $-5,572.00MM | $-5,167.00MM | $-1,344.00MM |
| Financing Cash Flow | $-3,349.00MM | $1,193.00MM | $-1,738.00MM |
| Earnings Per Share** | $25.69 | $25.68 | $25.53 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.